New study shows bivalent COVID-19 booster increases antibody response in lung cancer patients Post author: Post published:November 23, 2023 Post category:uncategorized Bivalent booster dose enhanced neutralization of Omicron XBB (sub)variants in non-small cell lung cancer (NSCLC) patients. You Might Also Like This Company Is Racing to Create the World’s First Noninvasive CGM December 11, 2023 New rice discovery could be good news diabetics and rice lovers October 22, 2023 Artificial variants of Withanolides act highly specifically against leukemia cells June 21, 2024